• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Amarin Corporation plc (AMRN)

    -NasdaqGM
    0.99 Down 0.00(0.21%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:0.99
    Open:1.00
    Bid:0.69 x 100
    Ask:N/A
    1y Target Est:1.86
    Beta:0.61
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:0.98 - 1.01
    52wk Range:0.78 - 2.75
    Volume:713,308
    Avg Vol (3m):1,865,520
    Market Cap:173.12M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMRN

    Comparison

    Symbol% ChgMkt Cap
    AMRNDown 0.21%173.12M
    MRKUp 0.44%163.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.59
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-0.02

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback